慢性肝病营养评估的CT影像指标及其应用

摘要/Abstract

摘要： 营养不良常发生于慢性肝病患者,并与肝功能失代偿、感染、死亡和肝移植后预后较差的风险增加有关,临床上对于肝病患者的营养状态评估逐渐受到重视。最近几年,影像技术在营养评估中发挥越来越重要的作用,其营养评价指标主要包括骨骼肌指数(SMI)、内脏和皮下脂肪组织面积比(VSR)及腰肌横向厚度指数(TPTI)等指标,这些指标未来很有潜力成为临床评估慢性肝病患者营养状态的客观指标。

关键词: 营养评估, 营养不良, 肝病, 筛查

邱婉春, 李俊峰, 毛小荣, 蒋妮. 慢性肝病营养评估的CT影像指标及其应用[J]. 肝脏, 2022, 27(7): 818-821.

[1] Carey Elizabeth J,Lai Jennifer C, Christopher S,et al. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.Hepatology, 2019, 70: 1816-1829.
[2] Berardi G, Antonelli G, Colasanti M,et al. Association of Sarcopenia and Body Composition With Short-term Outcomes After Liver Resection for Malignant Tumors. JAMA Surg,2020,155(11):e203336.
[3] Ebadi M, Tandon P, Moctezuma-Velazquez C,et al. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol,2018,69(3):608-616.
[4] Carey EJ,Lai JC,Wang CW,et al. A multicenter study to define sarcopenia in patients with end-stage liver disease.Liver Transpl,2017,235:625-633.
[5] Benmassaoud A, Roccarina D, Arico F,et al. Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites. Am J Gastroenterol,2020,115(11):1911-1914.
[6] Hong HC, Hwang SY, Choi HY,et al.Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology,2014,59(5):1772-1778.
[7] 李侗曾,孔明,宋文艳,等.慢加急性肝衰竭患者第三腰椎骨骼肌指数与临床指标的关系.实用肝脏病杂志,2020,23(04):467-470.
[8] Nishikawa H,Shiraki M,Hiramatsu A,et al. Japan society of hepatology guidelines for sarcopenia in liver disease (1stedition): Recommendation from the working group for reation of sarcopenia assessment criteria. Hepatol Res,2016,46(10):951-963.
[9] Kim G, Lee SE, Lee YB,et al. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. Hepatology,2018,68(5):1755-1768.
[10] Shih KL, Su WW, Chang CC, et al. Comparisons of parallel potential biomarkers of 1H-MRS measured hepatic lipid content in patients with non-alcoholic fatty liver disease. Sci Rep,2016,6:24031.
[11] Kappus MR, Wegermann K, Bozdogan E,et al. Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease. Liver Transpl,2020,26(9):1090-1099.
[12] Kaido T, Tamai Y, Hamaguchi Y,et al. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation. Nutrition,2017,33:195-198.
[13] Shoreibah MG, Mahmoud K, Aboueldahab NA,et al.Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score?Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic?Shunts. J Vasc Interv Radiol,2019,30(2):154-161.
[14] Romagna ES, Appel-da-Silva MC, Suwa E,et al.Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study. Sao Paulo Med J,2020,138(2):152-157.
[15] Lee SW, Son JY, Kim JM,et al. Body fat distribution is more predictive of all-cause mortality than overall adiposity. Diabetes Obes Metab,2018,20(1):141-147.
[16] Hamaguchi Y, Kaido T, Okumura S,et al.Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr,2020,39(6):1885-1892.
[17] Kamo N, Kaido T, Hamaguchi Y,et al.Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Clin Nutr,2019,38(5):2202-2209.
[18] Dong QT, Cai HY, Zhang Z,et al.Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: A comprehensive analysis from a large-scale prospective study. Clin Nutr,2021,40(5):3360-3369.
[19] Fujiwara N, Nakagawa H, Kudo Y,et al.Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol,2015,63(1):131-140.
[20] Hamaguchi Y, Kaido T, Okumura S,et al.Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma. Liver Cancer,2019,8(2):92-109.
[21] Hamaguchi Y, Kaido T, Okumura S,et al.Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation. J Cachexia Sarcopenia Muscle,2018,9(2):246-254.
[22] Lee YH, Jung KS, Kim SU,et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). J Hepatol,2015,63(2):486-93.
[23] Fujiwara N, Nakagawa H, Kudo Y,et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol,2015,63(1):131-40.
[24] Macshut M, Kaido T, Yao S,et al.Visceral adiposity is an independent risk factor for high intra-operative blood loss during living-donor liver transplantation; could preoperative rehabilitation and nutritional therapy mitigate that risk? Clin Nutr,2021,40(3):956-965.
[25] Huguet A, Latournerie M, Debry PH,et al.The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation: A retrospective cohort study. Nutrition,2018,51-52:73-79.
[26] 韩芳,肖慧娟,张翔,等.肝硬化及肝细胞癌患者腰肌横向厚度指数与营养风险的相关性分析.临床肝胆病杂志,2020,36(08):1753-1756.
[27] Praktiknjo M, Book M, Luetkens J, et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology,2018,67(3):1014-26.
[28] 胡振民,张树生.进行性肌营养不良症的CT诊断:附11例临床及CT分析.中华放射学杂志,1990,24(6):348-350.

慢性肝病营养评估的CT影像指标及其应用

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李善宝, 陆晶, 宋方彬, 徐军明. 超越MELD评分的新策略和新技术在肝移植中的应用[J]. 肝脏, 2022, 27(7): 739-741.
[2]	钱怡婷, 杨文卓. 生活方式干预防治非酒精性脂肪性肝病的现状[J]. 肝脏, 2022, 27(7): 822-825.
[3]	徐旭, 范建高. 非酒精性脂肪性肝病相关肝细胞癌面临的挑战[J]. 肝脏, 2022, 27(6): 620-621.
[4]	徐强, 王亚年, 吴炎. FONTAN术后相关性肝病研究进展[J]. 肝脏, 2022, 27(6): 624-627.
[5]	刘希, 廖杉, 刘小乖. 熊去氧胆酸治疗胆汁淤积性肝病患儿的临床疗效及对血清炎症指标及肠道菌群的影响[J]. 肝脏, 2022, 27(6): 703-707.
[6]	郭蕊, 崔莹, 王诗美, 樊微微, 胡晓丽. 慢性肝病患者相关骨病的研究进展[J]. 肝脏, 2022, 27(6): 711-715.
[7]	李玉川, 王建设. 儿童肝病紧急事件的早期识别和处理[J]. 肝脏, 2022, 27(5): 505-507.
[8]	苑广菲, 孙悦, 孟方园, 高沿航. 酒精性肝病未被满足的临床需求与挑战[J]. 肝脏, 2022, 27(5): 508-510.
[9]	王晓伟, 孙静, 王栋. 非酒精性脂肪性肝病对儿童和青少年慢性乙型肝炎抗病毒治疗反应的影响[J]. 肝脏, 2022, 27(5): 557-560.
[10]	刘小菊, 武丽娜, 刘立伟, 刘金香, 朱志军, 孙丽莹, 赵新颜. 19例进行性家族性肝内胆汁淤积的临床及病理特点分析[J]. 肝脏, 2022, 27(5): 561-565.
[11]	王铁钢, 李小明, 朱丹阳. 不同肝组织学特征非肥胖型NAFLD患者磁共振质子密度脂肪分数表现[J]. 肝脏, 2022, 27(5): 573-575.
[12]	南当当, 郭涛, 高荣建, 韩瑞瑞, 李士新. 代谢相关脂肪性肝病与急性胰腺炎的关系[J]. 肝脏, 2022, 27(5): 603-605.
[13]	郑文凯, 刘建军, 刘研, 王江红, 任燕军. 终末期肝病周围循环功能障碍发生原因和机制与临床关系[J]. 肝脏, 2022, 27(5): 606-609.
[14]	雷轶, 李丹, 姬素渊, 戴雪喻, 李斌. 肥大细胞在肝病中的研究进展[J]. 肝脏, 2022, 27(4): 385-388.
[15]	柳涛, 刘雅丽, 肖鹏, 高沿航. 遗传变异对酒精性肝病的影响[J]. 肝脏, 2022, 27(4): 389-390.